Copyright
©The Author(s) 2023.
World J Gastrointest Oncol. Jul 15, 2023; 15(7): 1149-1173
Published online Jul 15, 2023. doi: 10.4251/wjgo.v15.i7.1149
Published online Jul 15, 2023. doi: 10.4251/wjgo.v15.i7.1149
Ligands/biomolecules | Cell lines | Targeting gene/G-quadruplex | Effects on G-quadruplex | Effects on genes | Anticancer phenotypes | Ref. |
Tetrasubstituted naphthalene diimide ligands | PANC-1, MIA PaCa-2, HPAC, BxPc-3 | Telomere | Induced formation of a parallel G-quadruplex | Inhibited the binding of hPOT1 and topoisomerase IIIα to telomeric DNA | Cytotoxicity | [129] |
Tetrasubstituted naphthalene diimide derivatives (compounds 3d) | MIA PaCa-2 | Telomere | Retained high affinity to human telomeric G-quadruplex | Upregulated some DNA damage responsive genes, downregulated some telomere maintenance genes | Induced cellular senescence but did not inhibit telomerase activity | [130] |
Naphthalene diimide isomer ligands (compounds 2-5) | MIA PaCa-2, PANC-1 | HSP90 | Stabilized G-quadruplex structure | Not detected | Inhibited cell proliferation | [131] |
Tetrasubstituted naphthalene diimide derivative (MM41) | MIA PaCa-2 | BCL-2, K-RAS | Bound and stabilized G-quadruplex structure | Downregulated expression of BCL-2, K-RAS | Promoted cell apoptosis, decreased tumor growth of MIA-Pa-Ca2 xenografts | [132] |
Tetrasubstituted naphthalene diimide derivative (CM03) | MIA PaCa-2, PANC-1 | Not detected | Increased presence of nuclear G-quadruplex | Induces DNA damage, downregulated expression of Gli4, PLXNA1, PRKCZ, MAPK11, PARD6A, CBFA2T3 | Decreased tumor growth of MIA-Pa-Ca2 xenografts | [133-135] |
Tetrasubstituted naphthalene diimide derivative (SOP1812) | MIA PaCa-2, PANC-1, Capan-1, BXPC-3 | hTERT, telomere | Had affinity with G-quadruplex | Downregulated expression of WNT5B, DVL1, AXIN1, APC2, GLI1, MAPK11, BCL-2, hTERT | Inhibited cell proliferation, reduced MIA PaCa-2 xenograft growth | [135] |
Tetrasubstituted naphthalene diimide derivative (BMSG-SH3) | MIA PaCa-2 | HSP90 | Stabilized G-quadruplex structure | Not detected | Reduced telomerase activity and HSP90 expression, 50% decreased tumor growth of MIA-Pa-Ca2 xenografts | [136] |
Cationic alkyl-substituted porphyrin compound C14 | PANC-1 | KRAS | Bound with G-quadruplex and protoxidized the guanines | Downregulated expression of KRAS | Induced cell growth arrest | [137] |
Alkyl cationic porphyrins | MIA PaCa-2, PANC-1 | KRAS mRNA, NRAS mRNA | Bound G-quadruplex | Downregulated expression of KRAS, NRAS only if photoactivated | Activated apoptosis, reduced the metabolic activity of pancreatic cancer cells and the growth of a PANC-1 xenograft | [138] |
Porphyrin derivative (Octaacetyl) | PANC-1, MIA PaCa-2 | KRAS | Bound and stabilized G-quadruplex | Downregulated expression of KRAS | Cytotoxicity, induced apoptosis, blocked metastasis by inhibiting epithelial to mesenchymal transition | [139] |
Porphyrin derivative (Tetrakis) | PANC-1, MIA PaCa-2 | KRAS | Bound and stabilized G-quadruplex | Downregulated expression of KRAS | Cytotoxicity, induced apoptosis, blocked metastasis by inhibiting epithelial to messenchymal transition | [139] |
Porphyrin derivative (5Me) | PANC-1 | Telomere, Bcl-2, c-MYC, KRAS | Bound and stabilized G-quadruplex | Not detected | Inhibited cell proliferation, arrest G2/M phase cell cycle | [140] |
TMPyP4 | MIA PaCa-2 | Intermolecular G-quadruplex | Not detected | Shortened telomeres | Cytotoxicity, arrested cell proliferation, induced anaphase bridges, cellular senescence and apoptosis | [141] |
Telomestatin | MIA PaCa-2 | Intramolecular G-quadruplex | Not detected | Shortened telomeres | Cytotoxicity, arrested cell proliferation, and induced cellular senescence and apoptosis | [141] |
Nitidine | AsPC-1, BxPC-3, MIA PaCa-2, PANC-1 | KRAS | Bound and stabilized G-quadruplex structure | Downregulated expression of KRAS | Cytotoxicity | [142] |
4,11-bis(2-Aminoethy- llamino)anthra[2,3-b]furan-5,10-dione(2a),11-bis(2-aminoethylamino) anthra[2,3b]thiophene-5,10-dione (2b) | PANC-1 | KRAS mRNA | Bound and stabilized G-quadruplex | Inhibited translation of KRAS | Induced apoptosis, inhibited cell growth and colony formation | [143] |
Unsymmetrical bisacridines derivatives | PANC-1, MIA PaCa-2, BXpC-3, AsPC-1, Capan-2 | Telomere, c-MYC, KRAS | Bound and stabilized G-quadruplex | Not detected | Inhibited cell proliferation, reduced PANC-1 and MIA PaCa-2 xenograft growth in vivo | [144] |
Copper(ii) l/d-valine-(1,10-phen) complexes (complex 1a, 1b) | BxPC3, AsPC1 | Telomere | Had affinity with G-quadruplex | Not detected | Cytotoxicity | [145] |
CX-5461 (Pidnarulex) | MIA PaCa-2, PANC-1 | Telomere, c-MYC, c-kit | Bound with G-quadruplex | Not detected | Inhibited cell proliferation | [146,147] |
CX-3543 (Quarfloxin) | MIA PaCa-2 | Nucleolin/ribosomal DNA G-quadruplex complexes | Disrupts nucleolin/G-quadruplex complexes on ribosomal DNA | Inhibited rRNA synthesis | Inhibited proliferation, inhibited Pol I transcription, induced apoptosis, decreased tumor growth of MIA PaCa-2 xenografts | [148,149] |
Antihelminthic pyrvinium pamoate | PANC-1, Capan-1, HS766T, CFPAC, MIA PaCa-2 | Mitochondrial DNA | Bound G-quadruplex | Inhibited transcription of mitochondrial RNA | Inhibited cell viability, mitochondrial pathways, tumor growth of MIA PaCa-2 xenografts | [150] |
NSC 317605 and novel indoloquinolines | AsPc1, PANC1, BxPc3, MIA PaCa-2 | c-MYC, KRAS | Bound and stabilized G-quadruplex | Downregulated expression of KRAS | Cytotoxicity | [151] |
Quinazoline-pyrimidine derivatives | Tumor-naïve pancreatic stellate cells | Telomere, c-MYC, c-kit, KRAS, BCL-2 | Bound and stabilized G-quadruplex | Not detected | Inhibited tumor growth | [152] |
hnRNPA1 and integrinlinked kinase | AsPC-1, PANC-1, MIA PaCa-2, Capan-2 | KRAS | Destabilized G-quadruplex | Stimulated transcription of KRAS | Promoted KRAS-E2F1-ILK-hnRNPA1 circuitry, tumor growth and aggressive phenotypes | [153-155] |
Poly [ADP-ribose] polymerase 1 | PANC-1 | KRAS | Destabilized G-quadruplex | Stimulated transcription of KRAS | Activated a ROS-G-quadruplex-PARP-1 axis | [156] |
Apurinic/apyrimidinic endonuclease 1 | PANC-1, BxPc3, MIA PaCa-2 | KRAS | Bound and stabilized G-quadruplex | Upregulated expression of KRAS | Did not sensitize pancreatic cancer cells to chemotherapeutic drugs in vitro and in vivo | [157] |
Polypurine reverse Hoogsteen hairpins | AsPc-1, MIA PaCa-2 | KRAS, c-MYC | Bound and stabilized G-quadruplex | Inhibited transcription of KRAS and c-MYC | Inhibited cell proliferation | [158,159] |
- Citation: Han ZQ, Wen LN. Application of G-quadruplex targets in gastrointestinal cancers: Advancements, challenges and prospects. World J Gastrointest Oncol 2023; 15(7): 1149-1173
- URL: https://www.wjgnet.com/1948-5204/full/v15/i7/1149.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i7.1149